Clinical Trial Update: mFOLFOX6 Combined With Dalpiciclib in Patients With Metastatic Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating mFOLFOX6 plus dalpiciclib in advanced/metastatic colorectal cancer is in progress with unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Dalpiciclib (dalpiciclib)
• MFOLFOX6

Snippet

Sponsor: Sixth Affiliated Hospital, Sun Yat-sen University | Conditions: Advanced/Metastatic Colorectal Cancer | Phase 2 | Status: UNKNOWN